STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
60 hedge funds and large institutions have $167M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
60
Holders Change
-1
Holders Change %
-1.64%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
15
Reduced
25
Closed
13
Calls
$88K
Puts
$278K
Net Calls
-$190K
Net Calls Change
-$190K
Top Buyers
| 1 |
CC
Commodore Capital
New York
|
$21.8M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
$4.56M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
$4.54M |
| 4 |
SC
Samlyn Capital
New York
|
$11.2M |
| 5 |
NMC
NEA Management Company
Timonium,
Maryland
|
$22.2M |
Top Sellers
| 1 |
BlackRock
New York
|
$884K |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
$0 |
| 3 |
Morgan Stanley
New York
|
$2.48M |
| 4 |
State Street
Boston,
Massachusetts
|
$130K |
| 5 |
Norges Bank
Oslo,
Norway
|
$236K |
